Suppr超能文献

影响流感疫苗免疫反应的因素。

Factors affecting immune responses to the influenza vaccine.

机构信息

a Department of Infectious Diseases , Istituto Superiore di Sanità , Rome , Italy.

出版信息

Hum Vaccin Immunother. 2018 Mar 4;14(3):637-646. doi: 10.1080/21645515.2017.1338547. Epub 2017 Jul 21.

Abstract

Annual administration of the seasonal influenza vaccine is strongly recommended to reduce the burden of disease, particularly for persons at the highest risk for the viral infection. Even during years when there is a good match between the vaccine and circulating strains, host-related factors such as age, preexisting immunity, genetic polymorphisms, and the presence of chronic underlying conditions may compromise influenza vaccine responsiveness. The application of new methodologies and large-scale profiling technologies are improving the ability to measure vaccine immunogenicity and our understanding of the immune mechanisms by which vaccines induce protective immunity. This review attempts to summarize the general concepts of how host factors can contribute to the heterogeneity of immune responses induced by influenza vaccines.

摘要

建议每年接种季节性流感疫苗,以减轻疾病负担,尤其是对感染病毒风险最高的人群。即使在疫苗与流行株匹配良好的年份,宿主相关因素,如年龄、预先存在的免疫、遗传多态性和慢性基础疾病的存在,也可能影响流感疫苗的反应性。新方法的应用和大规模分析技术提高了衡量疫苗免疫原性的能力,并加深了我们对疫苗诱导保护性免疫的免疫机制的理解。本综述试图总结宿主因素如何导致流感疫苗诱导的免疫反应异质性的一般概念。

相似文献

1
Factors affecting immune responses to the influenza vaccine.
Hum Vaccin Immunother. 2018 Mar 4;14(3):637-646. doi: 10.1080/21645515.2017.1338547. Epub 2017 Jul 21.
2
Immunogenicity and safety of a split-virion quadrivalent influenza vaccine in adults 18-60 years of age in the Republic of Korea.
Hum Vaccin Immunother. 2018 Mar 4;14(3):587-592. doi: 10.1080/21645515.2017.1381808. Epub 2017 Nov 17.
3
Universal influenza vaccines, science fiction or soon reality?
Expert Rev Vaccines. 2015;14(10):1299-301. doi: 10.1586/14760584.2015.1060860. Epub 2015 Jun 23.
4
The use of cell-mediated immunity for the evaluation of influenza vaccines: an upcoming necessity.
Hum Vaccin Immunother. 2019;15(5):1021-1030. doi: 10.1080/21645515.2019.1565269. Epub 2019 Feb 20.
8
The human antibody response to influenza A virus infection and vaccination.
Nat Rev Immunol. 2019 Jun;19(6):383-397. doi: 10.1038/s41577-019-0143-6.
9
Immunogenicity and safety of the 2015 Southern Hemisphere formulation of a split-virion inactivated quadrivalent vaccine.
Hum Vaccin Immunother. 2018 Mar 4;14(3):593-595. doi: 10.1080/21645515.2017.1377378. Epub 2017 Oct 30.
10
Immunogenicity, safety and tolerability of intradermal influenza vaccines.
Hum Vaccin Immunother. 2018 Mar 4;14(3):565-570. doi: 10.1080/21645515.2017.1328332. Epub 2017 Jul 6.

引用本文的文献

1
Synthetic Neuraminidase Vaccine Induces Cross-Species and Multi-Subtype Protection.
Vaccines (Basel). 2025 Mar 28;13(4):364. doi: 10.3390/vaccines13040364.
3
Memory B cell proliferation drives differences in neutralising responses between ChAdOx1 and BNT162b2 SARS-CoV-2 vaccines.
Front Immunol. 2025 Mar 24;16:1487066. doi: 10.3389/fimmu.2025.1487066. eCollection 2025.
5
Neutralizing antibodies against SARS-CoV-2 of vaccinated healthcare workers in Taiwan.
Ann Med. 2025 Dec;57(1):2442533. doi: 10.1080/07853890.2024.2442533. Epub 2024 Dec 23.
6
Influenza B Virus Vaccine Innovation through Computational Design.
Pathogens. 2024 Sep 2;13(9):755. doi: 10.3390/pathogens13090755.
9
Safety and effectiveness of baloxavir marboxil and oseltamivir for influenza in children: a real-world retrospective study in China.
Front Pediatr. 2024 Jul 29;12:1418321. doi: 10.3389/fped.2024.1418321. eCollection 2024.

本文引用的文献

2
Optimal timing of influenza vaccination during 3-week cytotoxic chemotherapy cycles.
Cancer. 2017 Mar 1;123(5):841-848. doi: 10.1002/cncr.30468. Epub 2016 Dec 20.
3
Influenza virus-specific antibody dependent cellular cytoxicity induced by vaccination or natural infection.
Vaccine. 2017 Jan 5;35(2):238-247. doi: 10.1016/j.vaccine.2016.11.082. Epub 2016 Nov 30.
4
Immunosenescence-Related Transcriptomic and Immunologic Changes in Older Individuals Following Influenza Vaccination.
Front Immunol. 2016 Nov 2;7:450. doi: 10.3389/fimmu.2016.00450. eCollection 2016.
5
Potent protection against H5N1 and H7N9 influenza via childhood hemagglutinin imprinting.
Science. 2016 Nov 11;354(6313):722-726. doi: 10.1126/science.aag1322.
7
Aging of the immune system: Focus on inflammation and vaccination.
Eur J Immunol. 2016 Oct;46(10):2286-2301. doi: 10.1002/eji.201546178.
8
Prevention and Control of Seasonal Influenza with Vaccines.
MMWR Recomm Rep. 2016 Aug 26;65(5):1-54. doi: 10.15585/mmwr.rr6505a1.
9
Sex differences in immune responses.
Nat Rev Immunol. 2016 Oct;16(10):626-38. doi: 10.1038/nri.2016.90. Epub 2016 Aug 22.
10
Obesity Outweighs Protection Conferred by Adjuvanted Influenza Vaccination.
mBio. 2016 Aug 2;7(4):e01144-16. doi: 10.1128/mBio.01144-16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验